Evidence map›Paper›PMID 30810767›Full record

ArticleDiabetologia2019

Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence.

Oskar Skog, Karin Klingel, Merja Roivainen, Olle Korsgren

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Diabetologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. A viral link for type 1 diabetes.Nature medicine · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Oskar SkogDepartment of Immunology, Genetics and Pathology, The Rudbeck Laboratory C11, Clinical Immunology, Uppsala University, Dag Hammarskjölds väg 20, 751 85, Uppsala, Sweden. oskar.skog@igp.uu.se.ORCID http://orcid.org/0000-0001-9713-722X
Karin KlingelInstitute for Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany.
Merja RoivainenNational Institute for Health and Welfare, Helsinki, Finland.
Olle KorsgrenDepartment of Immunology, Genetics and Pathology, The Rudbeck Laboratory C11, Clinical Immunology, Uppsala University, Dag Hammarskjölds väg 20, 751 85, Uppsala, Sweden.
Uppsala University · SEFinnish Institute for Health and Welfare · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsDiabetes Mellitus, Type 1EnterovirusEnterovirus InfectionsHumansVaccinationAntiviral AgentsAutoimmunityBeta cellsDiViD studyEnterovirusPancreasPreventionType 1 diabetesVirusVP1

Identifiers

PMID30810767
OpenAlexW2915582734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.